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The FDA estimates that 35% of Americans 
regularly consume aspartame, an artificial sweetener used 
in diet drinks and other sugar-free food items. Some 
anecdotal reports indicate the substance has been 
associated with health, behavioral, and cognitive 
concerns. The FDA and other regulatory agencies 
indicate it is safe for use up to 50mg/kg/day. They 
further advise individuals with metabolic phenylalanine 
disorders not to consume this product. This conflicting 
advice has caused confusion for consumers and 
practioners. Therefore, the purpose of this study was to 
examine the effects of aspartame consumption on cognitive 
functioning of healthy adults.
Orem's theory of Self-Care guided this descriptive, 
clinical study. The effect of dietary aspartame 
consumption on cognitive function of study participants 
was monitored and analyzed for participants consuming 
weighed food intakes for 16 days.
This study tested the hypothesis that cognitive
viii
functioning is poorer when participants' dietary intake 
of aspartame is higher. The sample population was 
comprised of 180 randomly selected ethnically-diverse 18 
to 40 year old healthy adults recruited through a 
midwestern university. Instruments used for measurement 
included a Demographic Questionnaire, Weighed Food 
Intakes, Kearney and Fleischer's Exercise of Self-care 
(alpha= .80), the Sternberg Item Recognition Test (r 
=.95), and the Vandenberg Mental Rotation Test (KR- 
20= .88).
Depending on the cognitive task (the Vandenberg 
Mental Rotation Test), results indicated that cognitve 
function was significantly better (p=.03) when 
participants consumed less aspartame (<1000mg/day) than 
those who consumed more (>1000mg/day).
The relevance of these results is that healthcare 
professionals need to be aware of dietary factors that 
can maximize cognitive function and promote quality of 
life for their clients.
IX
CHAPTER I
INTRODUCTION AND REVIEW OP LITERATURE 
A healthy lifestyle is essential for health promotion 
and disease prevention. Proper dietary intake is one of 
the key factors for living healthily. Although dietary 
intakes have been well-recognized as a significant 
contributor to "health," people do not pay much attention 
to what they eat and "Americans consume much more sugar 
than they need" (Stadler & Essa, 2001, p.3) . According to 
the Federal Continuing Survey of Food Intakes (1994-1996), 
the average American consumes an amount of sugar 
substitutes equivalent to 20 teaspoons of sugar per day — 
equal to about 80 grams of sugar (Henkel, 2004). The Food 
and Drug Administration (1987) estimates 35% of Americans 
regularly consume aspartame, which is one of the most 
widely-used sugar substitutes. Used as an artificial low- 
calorie sweetener, aspartame has undergone numerous 
studies regarding safety issues since its approval by the 
FDA in 1981. Some anecdotal reports indicate aspartame 
has been associated with health, behavioral, and 
cognitive function; and about two-thirds of these
1
symptoms were neurobehavioral in nature (Butchko & 
Stargel, 2001). The FDA (2004) and other food regulatory 
agencies indicate that aspartame may be safe for use up 
to 50mg/kg/day. Based on this conflicting information, it 
seems important to determine what amount of aspartame 
consumption would be considered safe for general use.
Purpose
The purpose of our study was to examine the effects 
of aspartame consumption on cognitive function of healthy 
adults, testing the hypothesis that cognitive functioning 
was poorer when participants' dietary intakes of 
aspartame were greater.
Significance of the Study
The effects of aspartame and its metabolic breakdown 
products (phenylalanine, aspartic acid, and methanol) 
have been investigated in general populations as well as 
in subgroups. Along with these concerns, rising safety 
issues related to aspartame consumption have been 
reported in studies, such as the onset of brain tumors 
and seizures, headaches, allergies, behavioral changes, 
and changes in cognitive function (European Scientific 
Committee on Food [ESCF] , 2002) . Among these studies, 
researchers have been increasingly paying attention to 
the effects of aspartame on cognitive function. Over the
2
years, it has been hypothesized that aspartame could have 
an effect on human cognition (Wurtman, 1985) . However, a 
number of studies show that there are no direct effects 
indicated in tests by administrating single doses of up 
to 60mg/kg/day (Lieberman et al, 1988; Lapierre et al., 
1990; Pivonka & Grunewald, 1990; Stokes et al . , 1991; 
Stokes et al., 1994).
Lapierre et al. (1990) conducted a clinical study
among ten healthy adult volunteers with administration of 
a single dose of aspartame (15 mg/kg body weight in 
capsules). Changes in mood, cognitive function, and 
memory were tested after aspartame administrations. The 
researchers of this study reported that no detectable 
differences were found between aspartame and placebo 
despite of significant increases in plasma phenylalanine 
levels after aspartame administration. Changes in mood 
were also tested by Pivonka and Grunewald in young women 
following aspartame-containing beverages consumption 
(1990) . However, Pivonka and Grunewald concluded that no 
significant mood changes were observed following 
aspartame consumption compared to water. Moreover, the 
effects of chronic aspartame consumption were also tested 
among pilots by Stokes et al. (1994). However, no
significantly declined cognitive performance observed
3
among study participants following chronic dosing of 
aspartame.
However, the results of these studies can be 
debated, since single dosing administrations do not 
reflect typical aspartame consumption patterns. 
Consequently, it suggests a more scientifically-designed, 
well-controlled clinical study to further evaluate the 
safe dosing issue.
This proposed study provided in-depth analysis of 
the safety of aspartame consumptions among healthy adults 
based upon more typical dietary intakes. Therefore, it 
was essential for individuals to consume food wisely and 
in a manner considered to be "healthy."
Review of Literature 
Aspartame's Role in the Diet
Aspartame, a dipeptide (L-aspartyl-L-phenylalaline 
methyl ester) used as a nonsugar sweetener, was 
discovered in 1965 and approved by the U.S. Food and Drug 
Administration in 1981 as safe for use in a wide range of 
food products. Today, aspartame is found in approximately 
6000 products, including soft drinks, chewing gums, 
gelatins, puddings, frozen desserts, yogurt, some 
pharmaceutics, and many other products (Calorie Control 
Council, 2004). It is chemically broken down into three
4
metabolic components (aspartic acid, phenylalanine, and 
methanol) in the body by hydrolysis of intestinal 
esterases (American Dietetic Association, 1998) .
Since it was approved by the FDA in 1981, aspartame has 
been used in thousands of products for more than 25 
years, and the amount of demand for aspartame use has 
been increasingly rising from 8.4 million pounds in 1986 
to 17.5 million pounds in 1992 (American Dietetic 
Association, 1998) .
As it is increasingly being used as a general- 
purpose sweetener, aspartame has been harshly criticized 
for its safety issues, including (1) the possible 
methanol toxicity; (2) the increased plasma 
concentrations of phenylalanine and aspartic acid in the 
brain; (3) the potential neuroendocrine alterations 
associated with elevated concentrations in the brain; and 
(4) a hypothesized connection between aspartame and 
epilepsy and brain malignancy (ESCF, 2002) . These safety 
issues related to aspartame and its breakdown metabolic 
components have been studied in children and general 
human populations (ESCF, 2002) . Shortly after heavy 
worldwide marketing of aspartame, numerous scientific 
studies were conducted to investigate these safety issues 
through clinical and laboratory research. According to
5
the report by Calorie Control Council (2004), aspartame 
has been considered to be safe in more than 200 studies, 
including studies by the U.S. Food and Drug 
Administration (FDA). However, this investigator cannot 
find the primary sources of the 200 studies stated above. 
Despite the safety statement about aspartame by 
regulatory agencies, however, there were many anecdotal 
reports of health effects related to aspartame 
consumption (Hull, 1999). In a report by the FDA (1995), 
numerous consumer complaint reports were received and 11% 
were considered serious. Given that 11% of the reports 
were considered serious, it seems there is a need for 
further investigation.
Aspartame Consumption and Evidence of 
No Significant Effects on Cognition 
The increased recent interest in the safety of 
aspartame has prompted investigators to explore whether 
there is a link or not between aspartame consumption and 
neurological effects as well as cognitive function. It 
has been hypothesized that aspartame might have the 
potential for affecting neurotransmitter levels in the 
brain since it is believed that a source of phenylalanine 
from dietary consumption of aspartame - containing products 
would increase phenylalanine concentrations in the brain.
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Wurtman (1985) further suggested that the increased level 
of phenylalanine in the brain may disturb the balances in 
monoaminergic neurotransmission, thereby, resulting in 
effects on cognition, behavior, and physiological 
functions. The hypothesis has been tested in a number of 
animal and clinical studies. Although effects on 
neurotransmitter levels were noted based on some acute 
and repeat-doses of administration at high doses in 
animal studies, there were no statistically significant 
and reproducible effects (Dailey, et al., 1991; Reilly & 
Laj tha, 1995) .
Furthermore, Spiers et al. (1998) conducted a
clinical research study to examine the aspartame effects 
on neuropsychologic and neurophysiologic functioning.
Each study participant was administered one of three 
treatments aspartame, sucrose, or placebo. The authors 
concluded that large daily doses of aspartame had no 
effects on neuropsychologic, neurophysiologic, or 
behavioral functioning in healthy young adults, and 
stated that aspartame is safe for the general population 
(Spiers et al., 1998). Another clinical study conducted 
to measure the neuropsychiatric effects of aspartame 
among healthy volunteers indicated that there were no 
significant differences between aspartame and the placebo
7
found in measures of sedation, hunger, headache, 
reaction-time, cognition, or memory at any given time 
during this study after ingestion of a single dose of 
aspartame (Lapierre et al., 1990).
Regardless of numerous negative research findings of 
aspartame studies, it is believed that there are still 
some questionable issues left for further evaluation due 
to a variety of anecdotal reports and debatable research 
methodology (Hull, 1999).
Aspartame Consumption and Evidence of 
Significant Effects on Cognition 
Although aspartame has shown little or no behavioral 
effect in most studies, Conners et al. (1986) stated that
activity observed following administration of sucrose or 
fructose was less than after aspartame. Conners et al. 
(1986) further reported that the improvement in attention 
might be considered declined because of aspartame.
Another research study has also been conducted on 
preschoolers who were treated with aspartame compared to 
glucose, sucrose, and saccharin. Following 
administration, their activities were observed (Kruesi, 
et al., 1985) . A significant decline of motor activity
was observed after aspartame administration, while other
8
behavioral measures did not demonstrate significant 
differences (Kruesi, et al.; 1985) .
Moreover, the U.S. Centers for Disease Control 
(1984) reviewed 517 cases of consumer adverse reaction 
complaint reports and concluded that 28% of the cases 
showed adverse reactions, such as headache, dizziness, 
mood changes, insomnia, nausea and vomiting, etc., 
occurred after aspartame-containing product consumption 
(Butchko & Stargel, 2001) .
A recent study conducted in rats by Christian, et 
al. (2004) reported that rats administered with aspartame
in the drinking water for three or four months showed a 
significant increase in time when performing T-maze 
activity. Potts et al. (1980) also reported that when
aspartame was administered as 9% of the diet for thirteen 
weeks, altered learning behaviors were observed in male 
rats.
Although there were no clinical studies to 
demonstrate the effects of aspartame consumption on poor 
neurobehavioral or cognitive function, some anecdotal 
reports have been presented to the FDA indicating adverse 
reactions associated with potential effects of consuming 
aspartame-containing products, for example, headache, 
dizziness, mood changes, nausea and vomiting, etc. (FDA,
9
view of the studies' conclusion discrepancies based on 
industry- and non-industry-sponsored research 
investigations, a more thorough and well-controlled study 
may be needed to generate a more scientific conclusion 
for the use and safety of aspartame consumption.
Aspartame and Health Status 
Although aspartame has been investigated for many 
health-related problems, there are not many studies done 
in healthy adults related to their health status, such as 
physiological measures—respiration, pulse, blood 
pressure, blood glucose, body weight, or temperature. One 
laboratory study conducted by Kiritsy and Maher (1986) 
reported that animals with aspartame administration could 
induce high blood pressure due to increased levels of 
phenylalanine concentrations in the blood and brain. 
Contrary to the findings of Kiritsy and Maher's study, 
Leon et al. (1989) concluded that there were no persistent
changes in vital signs (including temperature, 
respiration, blood pressure, and pulse) in participants 
consuming aspartame for 24 weeks.
Theoretical Framework
Orem's Theory of Self-Care guided this descriptive, 
clinical study. Our study examined the effects of 
participants' aspartame consumption on the dependent
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variable, that is, cognitive function. Orem's Theory of 
Self-Care has been widely used in nutrition studies 
(Owasoyo, et al, 1992; Lindseth and Lindseth, 1995). Self- 
care is defined as a significant factor for maintaining a 
high quality of life. Self-care agency is the capability 
of allowing patients to distinguish factors that need to 
be controlled to facilitate better regulation of their 
functioning and development (Orem, 1995). Self-care 
involves use of knowledge in order to promote health and a 
high-quality of life. Since self-care is a learned, goal- 
oriented activity, it was thus measured in our study to 
determine each participant's capabilities and determine 
the effectiveness of dietary changes intended to promote 
management of people's functioning and quality of life.
Research Questions
1. To what extent was cognitive function affected by 
higher aspartame consumption (a 1000 mg/day)
from dietary intake in comparison with lower dietary 
aspartame consumption (< 1000 mg/day)?
2. What was the relationship among cognitive function 
scores, dietary aspartame consumption, demographics, 
and health status in healthy participants?
Definitions
The definitions were used in the study as follows:
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1995). This indicates a demand for further investigation 
for its safe use.
Discrepancies among Studies 
The European Scientific Committee on Food (ESCF) 
concluded that here were no significant effects of 
aspartame consumption noted on behavior, mood, or EEG 
profiles, or cognitive function, even with elevated 
phenylalanine levels in the brain in long- and short-term 
clinical studies in either the general populations or 
sensitive individuals (2002). However, an analysis of 164 
studies, including 90 non-industry-sponsored and 74 
industry-sponsored studies, reviewed by Ralph Walton, 
Chairman of The Center for Behavioral Medicine and 
Professor of Clinical Psychiatry at Northeastern Ohio 
Universities College of Medicine, concluded that there 
were many questions left related to human safety. Of 
these 164 studies, among 90 non-industry-sponsored 
studies, 92% found one or more problems associated with 
aspartame. Among 74 industry-sponsored studies, 100% 
stated that there were no problems found (Aspartame 
Toxicity Information Center, 1996) . However, this 
investigator was not able to evaluate these one hundred 
sixty-four studies as mentioned above due to the lack of 
available primary sources reviewed in Walton's report. In
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Cognitive function was defined as enabling users "to
transform a (prescribed) task into an activity (effective 
task)" and was "experimentally elicited by interpreting 
the deviations between the task and user activity in 
terms of role, context, and resources" (Boy, 1998, p. 
266-267). These resources included user-based (e.g., 
knowledge and skills) and task-based (e.g., procedures) 
functions (Boy, 1998). Cognitive function was 
operationally measured for our study using the Vandenberg 
Mental Rotation Test (MRT) and Sternberg Item Recognition 
(SIR) Test.
Vandenberg Mental Rotation Test presented 
participants with a series of problems in which they were 
given a geometric figure as a target item and a row of 
four geometric figures as distracters, and the task was to 
select two of the four distracter items which is the same 
as the target items. The participants needed to complete 
20 questions within 6 minutes to earn a maximum score of 
40 on the test. MRT had a score of Kuder - Richardson 
internal consistency .88 and a test-retest reliability .83 
when tested for reliability (Vandenberg & Kuse, 1978).
Sternberg Item Recognition Test was used to test 
short term memory. For this test, a computer was used to 
present stimuli on a monitor and participants were given a
13
short list of items (typically digits), and they responded 
to each trial as quickly as they could, and the computer 
recorded their responses for approximately ten 
milliseconds. The coefficient for test-retest reliability 
for SIR test was a .95 (Sternberg, 1966) .
Assumptions
1. Individuals might not have been aware of how much 
aspartame they consumed in their daily lives since 
aspartame is increasingly used in almost 6,000 
products.
Limitations
1. This is a secondary analysis. Therefore, this
investigator had no control of variables because data 
was collected after participants' dietary intakes.
2. This is a secondary analysis. Therefore, this 
investigator had no control of the study groups and 
control group since all data was gathered after 
dietary treatments.
Summary
Although a number of studies showed that there was 
little or no direct effects of aspartame consumption on 
neurobehavioral or cognitive function, as discussed 
above, the question is still left to be discussed further 
due to the debatable study methodology and the
14
credibility of study conclusions. Further study needs to 
test consumer reported adverse reactions associated with 
aspartame consumption since some study results are still 
controversial. Overall, the purpose of the study was to 
examine the effects of aspartame consumption on the 





The purpose of our study was to examine the effects 
of aspartame consumption on cognitive function of healthy 
adults, testing the hypothesis that the cognitive 
functioning was poorer when participants' consumption of 
dietary aspartame intakes were greater.
This chapter focuses on the methodology employed in 
our study. The study population, sample, study design, 
data collection methods and procedures, instrument 
reliability and validity, data analysis, and the 
protection of human subjects are addressed in this 
chapter.
The research questions of our study were the 
following:
1. To what extent was cognitive function affected by 
higher aspartame consumption (> 1000 mg/day)
from dietary intake in comparison with lower dietary 
aspartame consumption (< 1000 mg/day)?
2. What was the relationship among cognitive function
16
scores, dietary aspartame consumption, demographics, 
and health status in healthy participants?
Population and Sample
The sample population was comprised of 180 randomly 
selected ethnically-diverse 18 to 40 year-old healthy 
adults recruited through a midwestern university. The 
criteria for inclusion were as follows: (a) 18 to 40 years 
of age; (b) capacity to read, understand, and speak 
English; and (c) enrollment in a midwestern university.
Study Design
Orem's Theory of Self-Care guided this clinical study 
using a descriptive, correlational study design. Each 
participant served as his or her own control when 
participating in the study. Amounts of aspartame 
consumption by each participant were calculated by a 
registered dietitian based upon the amount of aspartame 
contained in food products provided by the manufacturers. 
The data were recorded and analyzed from weighed food 
intakes for 16 days for comparison of cognitive testing 
mean scores on aspartame consumption.
Data Collection Methods/Procedures
This is a secondary analysis based upon the 
following clinical study which included food treatments.
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A registered dietitian and the study investigators 
were consulted about the dietary treatments. The purpose 
and details of the study were explained to the 
anticipating participants at an arranged meeting and 
questions were also answered by the researchers. 
Participants who signed the study consent forms completed 
questionnaires and had measurements taken for 
demographics, self-care agency, and anthropometries. 
Participants were randomly selected for the study. The 
participants met with the research team a week before 
treatments. On the treatment weeks, each participant was 
instructed to consume only the food and beverages provided 
for the study; moreover, the participants were instructed 
to complete questionnaires on a daily basis about that 
food consumption. The importance of compliance with the 
treatment plan was also addressed.
Dietary intakes were controlled in terms of what 
and how much was consumed. On the weeks of treatment, a 
weighed scheduled meal was given to each participant for 
16 days (three 4-day dietary treatments). A weighed food 
record was well-recognized as the most precise method for 
measuring individuals' food intakes according to Gibson 
(1990). Food portions were measured based upon 
individuals' kilocalories per day using indirect metabolic
18
calorimetry, and portion sizes were weighed before and 
after consumption. Beverages, such as juices and milk, 
were given to the participants with no limited amount as 
part of their meals. The participants' preferences of 
beverages were taken into account for their daily caloric 
intakes. However, only water and non-caloric drinks in 
addition to fluids provided at meals were issued and the 
amount of caffeine was carefully controlled in the study 
because of its potential effects on cognitive function 
with no more than 200 mg per day. Snacks were also issued 
to participants to take home for consumption between the 
evening meal and before midnight.
Meals were brought by the researchers or research 
assistants directly to each participant and served in a 
private study dining room at the university. Food 
preparation was completed with the consultation and under 
the guidance of a dietitian, and the researchers or 
research assistants confirmed that each meal was prepared 
properly before serving the participants. Amounts of 
aspartame were mainly analyzed for its potential effects 
on cognitive function.
Instrumentation and Reliability & Validity
This is a secondary analysis of the clinical study - 
"Nutritional Effects on Cognition and Flight Performance."
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Demographics. A Demographic Questionnaire was 
completed by each participant, including place of 
residence, age (in years), education (in years), 
marital/social living status, employment status, and 
ethnic identification.
Anthropometric measurements. Serial weights and 
weight-for-height measures were recorded, and body mass 
indices (BMI) were further calculated for each 
participant. The components of reliability for 
anthropometric measures were studied in both male and 
female participants from the Second National Health and 
Nutrition Examination Survey (NHANES II). The 
anthropometric measurements for our study (weight and 
height) had reliabilities greater than 0.97 (Marks, et 
al. , 1989) . Body weights were taken twice for each 
participant using a Cardinal-Detecto balance beam scale, 
at the beginning and at the end of each study week. Height 
was measured and recorded on the first visit by using an 
Accu-stat wall-mounted height board. BMIs, a ratio of 
weight for height based upon the measurement of each 
participant on admission, were calculated in accordance 
with the Quatelet Index (kg/m2) (Gibson, 1990) . In 
addition, serial weight was monitored to determine if the 
participant was considered underweight or overweight at
20
the beginning of the study and as a baseline for 
monitoring weight gains or losses during the study.
Health assessment data. The data of health status 
assessment modified from Doenge's Health Assessment 
Checklist (1989) was collected and recorded for each 
participant. The checklist consisted of nine factors, 
including history of chronic systemic disease such as 
heart disease, hypertension, respiratory insufficiency, 
diabetes; metabolic or GI disorders; and urinary or 
neurological disorders. To control for these disorders, 
data were eliminated if disorders from these systems are 
an interfering factor.
Dietary treatments. Weighed food intakes were used to 
calculate each participant's dietary aspartame intakes 
from their meals, by using the Food Processor-Genesis 
System to analyze a variety of extensive nutrients based 
on the U.S. RDA. Indirect calorimetry was used to 
determine the appropriate calorie levels, rather than BMI 
and activity levels. Confounding relationships between 
food process and food borne illnesses were controlled 
through closely monitored food distribution practices.
Self-care agency. Self-care agency was measured to 
determine the participants' abilities to take care of 
themselves with the reliability of Kearney and Fleischer's
21
Exercise of Self-Care Agency (alpha = .80) (Whetstone, 
1986) .
Cognitive Function Tests. Two psychometric measures, 
the MRT and the SIR test, were used to assess 
participants' cognitive functions. The MRT instrument 
presented participants with a series of problems in which 
they were given a geometric figure as a target item and a 
row of four geometric figures as distracters, and the 
task was to select two of the four distracter items which 
were the same as the target items. The participants 
needed to complete 20 questions within 6 minutes with a 
maximum score of 40 on the test. A Kruder-Richardson 
internal consistency coefficient was .88 when testing 
reliability of the Vandenberg Test of Mental Rotation 
(Vandenberg & Kurse, 1978). The SIR test was used to test 
short term memory. For this test, a computer was used to 
present stimuli on a monitor and participants were given 
a short list of items (typically digits), and they 
responded to each trial as quickly as they could, and the 
computer recorded their responses for approximately ten 
milliseconds. The coefficient of test-retest reliability 




The study data was analyzed by using the Statistical 
Package for Social Science (SPSS) . The SPSS Explore 
Procedure (2006) was utilized to screen data and to test 
for normality and homogeneity of variance. Demographic 
data was analyzed in our study in regards to each study 
participant, including the following: (a) the age; (2) the 
years of education received; (c) the body mass index; (d) 
the self-care agency score. The frequencies were evaluated 
for responses to the measures of dietary aspartame 
intakes, demographics, health status, and cognitive 
function. These data were analyzed by descriptive and 
inferential statistics. An alpha level of .05 was the 
criterion for significance.
Descriptive statistics and correlations were used to 
analyze the effects of dietary aspartame consumption by 
the participants when comparing their cognitive function 
levels during treatment measures. All data were 
quantified for analysis. Our study was conducted in 
accordance with the methods discussed above to examine 
the effects of aspartame consumption on cognitive 
function by using the descriptive and correlational 
statistics.
23
Protection of Human Subjects
The Institutional Review Boards of the university and 
the U.S. Army Biomedical Research Human Use Committee 
reviewed and approved the study regarding ethical 
considerations for the human subjects in the study. The 
researchers of our study also clearly explained to 
participants that the study was totally voluntary and all 
collected data will remain confidential and only the 
summative and collective results will be reported. Each 
participant was also assured that there was no way in 
which she/he could be identified.
The findings of our study would help healthcare 
professionals as well as each individual in the society to 
better understand the dietary aspartame consumption. This 
information would benefit both healthcare providers and 





The purpose of our study was to examine the effects 
of aspartame consumption on cognitive function of healthy 
adults, testing the hypothesis that the cognitive 
functioning was poorer when participants' dietary intakes 
of aspartame were greater.
This chapter focuses on the demographic 
characteristics of the sample used in our study.
The research questions of our study were the 
following:
1. To what extent was cognitive function affected by 
higher aspartame consumption (> 1000 mg/day)
from dietary intake in comparison with lower dietary 
aspartame consumption (< 1000 mg/day)?
2. What was the relationship among cognitive function 
scores, dietary aspartame consumption, demographics, 
and health status in healthy participants?
The Statistical Package for the Social Sciences 
(SPSS) program was utilized to analyze the result
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Demographic Characteristics 
Demographic data were analyzed in our study in 
regards to each participant as follows: (a) the age; (2) 
the years of education received; (c) the body mass index; 
(d) the self-care agency score. Ages of the study 
participants ranged from 18 to 40 years old. The analysis 
of the demographic characteristics of the study 
participants revealed that the mean age was 20.6 years 
with a standard deviation of 2.0. The average education 
years of the study participants was 13.6, and the standard 
deviation of education years was .98. The mean body mass 
index of the participants was 24.8 with a standard 
deviation of 3.5. The self-care agency mean scores of the 
study participants were 127.2, and the standard deviation 
was 13.7. These demographic data are illustrated in Table 
1 .




Means and Standard Deviations for Demographics, Health 
Status, and Self-Care Agency Data (n=176)
Variable SD Mean
Demographics of the sample
Age (Years) 20.6 2.0
Education (Years) 13.6 . 98
Health Status of the Participants
Body Mass Index (BMI) 24.8 3.5
Self-care Agency (Scores) 127.2 13.7
27
CHAPTER IV
RESULTS AND ANALYSIS 
Introduction
The purpose of our study was to examine the effects 
of aspartame consumption on cognitive function of healthy 
adults, testing the hypothesis that the cognitive 
functioning was poorer when participants' dietary intakes 
of aspartame were greater.
This chapter discusses the statistical analysis used 
and results obtained in our study.
The research questions of our study were the 
following:
1. To what extent was cognitive function affected by 
higher aspartame consumption (> 1000 mg/day)
from dietary intake in comparison with lower dietary 
aspartame consumption (< 1000 mg/day)?
2. What was the relationship among cognitive function 
scores, dietary aspartame consumption, demographics, 
and health status in healthy participants?
The Statistical Package for the Social Sciences 
(SPSS) program was utilized to analyze the results
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Research Question 1
The first research question was to examine to what 
extent cognitive function was affected by higher 
aspartame consumption (> 1000 mg/day) from dietary intake 
in comparison with lower dietary aspartame consumption (< 
1000 mg/day).
Of 180 study participants, 95 consumed aspartame 
equal to or greater than 1000 mg per day, and 78 consumed 
aspartame less than 1000 mg per day from their dietary 
intakes. Table 2 shows the amount of aspartame contained 
in some common products and its toxicity levels based on 
50mg/kg/d = toxic.
Vandenberg Mental Rotation Test Mean Scores and 
Aspartame Consumption
The MRT score differences of the participants were 
compared for aspartame consumption. The MRT scores were 
based upon measures of dietary aspartame intakes. The mean 
MRT cognition score of study participants who consumed 
aspartame equal to or greater than 1000 mg per day was 
14.8 with a standard deviation of 6.0, and the mean MRT 
score of study participants who consumed aspartame less 
than 1000 mg per day was 16.7 with a standard deviation of
obtained in our study and significance was set at the .05
level.
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5.6. With the MRT measure, a higher score indicates better 
cognitive performance.
Statistically significant differences for Table 3 
were based upon an analysis of the amount of aspartame 
consumption from food. The MRT scores were significantly 
different with mean scores of 14.8 (±6.0) and p=.03 when 
aspartame consumption equal to or greater than 1000 mg per 
day. The mean scores of cognitive measures are shown in 
Table 3, which illustrates between-subjects differences 





Carbonated drinks (12 oz) 5.56
Yogurt (8 oz) 8.06
Powdered soft drinks (12 oz) 8.33
Gelatin dessert (4 oz) 10.53
Fruit drinks - 10% fruit juice 14.29 
Ice cream (4 oz) 20.00
Pudding (4 oz) 40.00
Chewing gum - 1 stick 142.86
Vitamins - 1 Multivitamin 250.00
Breath mints - 1 mint 666.67











*Based on 50 mg/kg/d = Toxic
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Sternberg Item Recognition Mean Scores and
Aspartame Consumption
T-test analysis was utilized to examine the SIR 
score differences of study participants for their dietary 
aspartame consumptions. Mean SIR scores were 731.9 (± 
190.5) when aspartame consumption was equal to or greater 
than 1000 mg per day compared to 730.9 (±144.0) while 
aspartame consumption was less than 1000 mg per day. The 
SIR scores were based on measures of aspartame intakes 
from food. The between-subjects differences for the 
dietary aspartame intakes of the participants were 
analyzed by using a t-test. T-test analysis of effects of 
aspartame consumption showed no significant differences in 
scores using the SIR test as illustrated in Table 4.
Table 3
Comparison of MRT Mean Scores and Aspartame Consumption
Variable Aspartame 
< 1000 mg/day 
Mean SD
Aspartame 
> 1000 mg/day 




16.7 5.6 14.8 6.0 2.13 .03




Comparison of SIR Test Mean Scores and Aspartame 
Consumption
Variable Aspartame Aspartame
< 1000 mg/day > 1000 mg/day
Mean SD Mean SD t P
Cognitive Measures
Sternberg Item 
Recognition Scores 730.9 144.0 731.9 190.5 .04 NS
NS Significance*: p= <.05 
n= 16 9
Research Question 2
The second question examined by our study was what 
the relationship among cognitive function scores, dietary 
aspartame consumption, demographics, and health status in 
healthy participants was.
Pearson's Correlations were used to examine this 
relationship. Based upon Pearson Correlations, no 
significantly correlated relationships were indicated 
among dietary aspartame consumption and body weight, 
blood pressure, respirations, body temperature, glucose, 
self-care agency and the SIR test; however, it shows that 
aspartame was inversely correlated with the MRT. The MRT 
also had an inversely correlated relationship with the
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SIR test. The self-care agency scores also inversely 
correlated with the participants' measures for 
respiration, body weight, SIR scores, and MRT scores. 
Table 5 shows some significant intercorrelational 
variables for healthy adults in our study.
Table 5
Intercorrelations of Effects of Aspartame Consumption on 
Cognitive Function Scores with Demographic and Health 
Status Variables
Effects of Aspartame Consumption op Physiological Changes
Physiological measures (respiration and pulse) of 
the study participants were also compared for differences 
based on aspartame consumptions. The respiration scores
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were significantly different (p = .04) when comparing 
aspartame consumption equal to or greater than 1000 mg per 
day, which had a mean score of 22.4 (+ 15.96), to 
aspartame consumption less than 1000 mg per day, which had 
a mean score of 18.6 (± 6.95). However, T-test analysis 
did not find significant effects of aspartame consumption 
on pulse measure as indicated in Table 6.
Table 6
Comparison of Physiological Changes Mean Scores and
Aspartame Consumption
Variable Aspartame Aspartame
< 1000 mg/day > 1000 mg/day
Mean SD Mean SD t P
Physiological Measures
Respiration 18.6 6.95 22.4 15.96 2.05 . 04
Pulse 82.8 14.7 82.1 14.99 .32 NS




DISCUSSION, CONCLUSIONS, AND RECOMMENDATIONS
Introduction
The purpose of our study was to examine the effects 
of aspartame consumption on cognitive function of healthy 
adults, testing the hypothesis that cognitive function 
was poorer when participants' dietary intakes of 
aspartame were greater.
This chapter briefly summarizes study results 
followed by a discussion and then a section on study 
conclusions. Recommendations for education, practice, and 
research suggested by our study are also given.
The research questions of our study were the 
following:
1. To what extent was cognitive function affected by 
higher aspartame consumption (> 1000 mg/day)
from dietary intake in comparison to lower dietary 
aspartame consumption (< 1000 mg/day)?
2. What was the relationship among cognitive function 
scores, dietary aspartame consumption, demographics, 
and health status in healthy participants?
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Summary
Our study examined the effects of dietary aspartame 
consumption among study participants. It also tested the 
statistical relationships among cognitive function 
scores, dietary aspartame consumptions, demographics, and 
health status. The MRT and the SIR test were used to 
assess the extent to which cognitive function scores were 
affected by dietary aspartame consumption of study 
participants.
180 subjects participated in our study. Of these 
participants, 95 consumed dietary aspartame intakes equal 
to or greater than 1000 mg per day, and 78 consumed less 
than 1000 mg per day.
T-test analysis found statistically significant 
differences ( t = 2.13, p =.03)in the MRT scores among 
participants who consumed equal to or more than 1000 mg 
of aspartame per day in their diet when compared to 
participants who consumed less than 1000 mg per day. A t- 
test analysis did not find statistically significant 
differences in the SIR scores among study participants 
who consumed equal to or more than 1000 mg per day in 
their diet when compared to participants who consumed 
less than 1000 mg per day.
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Pearson's Correlations were used to examine the
relationships among cognitive function scores, aspartame 
consumption, demographics, and health status in healthy 
participants. Using the Pearson's correlation 
coeffecient, aspartame correlated significantly with the 
MRT (r = -.18, p = .05), which negatively correlated with 
the SIR test; however, a significant correlation between 
the SIR test with dietary aspartame consumption was not 
indicated. A Pearson's correlation test did not indicate 
significant relationships among dietary aspartame 
consumptions, body weight, blood pressure, respiration, 
body temperature, serum glucose, and self-care agency.
Dorothea Orem's Self-care Deficit Theory was used as 
the theoretical framework to guide this clinical study. 
Lack of knowledge about healthy dietary consumption is 
viewed as a self-care deficit. Therefore, healthcare 
professionals could help people overcome this deficit by 
providing appropriate education about healthy diets as 
well as healthier lifestyles.
Discussion
A major finding of this clinical study showed 
significant differences in cognitive function when 
comparing higher dietary aspartame consumption to lower 
dietary aspartame consumption using the MRT. This finding
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seems to reflect an earlier hypothesis that aspartame 
might have the potential for affecting neurotransmitter 
levels in the brain since it is believed that dietary 
consumption of aspartame-containing products could 
increase phenylalanine concentrations in the brain 
(Wurtman, 1985). Wurtman (1985) further suggested that 
the increased level of phenylalanine in the brain may 
have an impact on the balances in monoaminergic 
neurotransmission, consequently resulting in effects on 
cognition, behavior, and physiological function. The 
hypothesis was tested in a number of animal and clinical 
studies.
Similar to the results of our study using the MRT, a 
recent study conducted in rats by Christian et al. (2004)
found that rats treated with aspartame (250mg/kg/day) in 
the drinking water for three or four months showed a 
significant increase in time when doing T-maze 
performance. This may suggest a possible effect of long­
term aspartame consumption on memory. However, the 
finding of this animal study did not reflect the results 
of the SIR test in our study. In addition, altered 
learning behaviors were found in male rats with aspartame 
administration as 9% of the diet for thirteen weeks 
(Potts et al., 1980).
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One study reported that when observing children's 
activities following administration of 1.25mg/kg of 
sucrose or fructose activities were less than after 
aspartame consumption (Conners et al., 1986). It appears 
that aspartame might play a major role in increasing 
children's activity if the sugars are considered 
reference points. The researchers of this study further 
reported an improvement in attention among children with 
the sugars compared to the subgroup of thirteen children 
with aspartame administration. Conners et al., therefore, 
suggested that aspartame might be claimed to cause the 
decline in attention activity.
Another study has also been conducted on 32 
preschoolers with administration of 30mg/kg of aspartame, 
were observed in comparison with glucose, sucrose, and 
saccharin (Kruesi, et al., 1985) . When activity was 
observed in these children, a decline in motor activity, 
considered significantly less active in these 
preschoolers, was noted after aspartame administration, 
while other behavioral measures did not show significant 
differences (Kruesi, et al., 1985). The authors of this
study, therefore, concluded that the behavioral effects 
of acute aspartame consumption, if present, were viewed 
as subtle. They further pointed out that children
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considered relatively "slowing down" following aspartame 
consumption had higher "internalizing" scores on the 11 
Achenbach Child Behavior Checklist than children without 
"slowing down" did.
It is interesting to note that in our study the SIR 
test did not confirm Wurtman's hypothesis. The score 
differences of our study participants were compared for 
aspartame consumption; however, there were no significant 
effects of aspartame consumption on the SIR test. This 
finding concurs with the result of a clinical research 
study conducted by Spiers et al. (1998). Forty-eight
volunteers participated in the study, and each 
participant was treated with one of three treatments of 
aspartame, sucrose, or placebo. The authors concluded 
that large daily doses of aspartame had no significant 
effects on neuropsychologic, neurophysiologic, or 
behavioral functions in healthy young adults, although 
plasma phenylalanine concentrations were increased during 
aspartame treatment (Spiers et al., 1998).
This finding is also consistent with the results of 
a research study by Lapierre et al. (1990). In this
study, the neuropsychiatric effects of aspartame were 
monitored among ten healthy volunteers using visual 
analog scales, arithmetic test score, and brake-pedal
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reaction timer measures. The study results indicated that 
there were no significant differences between aspartame 
and the placebo detected in measures of reaction-time, 
cognition, or memory at any time during the study 
following a single dose of aspartame ingestion (Lapierre 
et al., 1990). Similar results were also reflected in 
other clinical investigations. For example, in one study, 
thirteen pilots were tested by using SPARTANS cognitive 
test. The authors reported that aspartame ingestion was 
not detrimental to impairment in skills essential for 
cognitive performance, and that performance was not 
degraded to any measurable degree (Stokes et al., 1991) .
A number of research studies were also carried out 
on children and potentially sensitive individuals to test 
whether aspartame consumption was related to cognitive 
and behavioral changes. Individuals diagnosed with PKU, 
depression, Parkinson's disease, Attention Deficit 
Disorder(ADD), epilepsy or other suspected seizures were 
studied. There were no effects observed in children 
regarding behavior, mood, or learning when aspartame was 
consumed at a single dose and multiple doses for up to 
two weeks (Saravis, et al., 1990; Shaywitz et al., 1994).
However, individuals with PKU must be restricted in their 
phenylalanine intakes from all food resources, including
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aspartame (Butchko & Stargel, 2001). The FDA (2004) 
further advises these individuals not to consume this 
product.
Treatment-related longer-term effects were also not 
noted in children with ADD (Shaywitz et al., 1994) . The 
same results were also indicated in a study of preschool 
children described as sugar sensitive by their parents 
(Wolraich, et al., 1994).Although effects on
neurotransmitter levels were noted based on some single 
and repeat-doses of aspartame administration at high dose 
levels in animal studies, Dailey et al. (1991) and Reilly
and Lajtha (1995) stated there were no statistically 
significant and reproducible effects. Similar results 
were also reported in studies with administration of 
single doses of up to 60mg/kg/day (Lieberman et al, 1988; 
Lapierre et al., 1990; Pivonka & Grunewald, 1990; Stokes 
et al., 1991; Stokes et al., 1994). The results of these 
studies can be debated, however, since single dosing 
administrations do not reflect chronic aspartame 
consumption.
Using correlational coefficients, there were no 
correlational relationships among dietary aspartame 
consumption, health status, and physiological measures, 
such as body temperature, weight, blood pressure,
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respirations, and random glucose. Although in our study a 
significant relationship between dietary aspartame 
consumption and body physiological changes such as blood 
pressure and body temperature was not indicated, a study 
conducted by Kiritsy and Manor (1986) concluded that the 
neurochemical changes produced by aspartame could lead to 
significant changes in blood pressure. In this laboratory 
study on rats, Kiritsy and Maher (1986) reported that 
animals receiving aspartame injections could induce 
hypertension because of increased levels of phenylalanine 
in the blood and brain. They further pointed out that 
elevated levels of phenylalanine could be hydrolyzed to 
tyrosin in the liver, which can lead to blood pressure 
changes.
In our study, physiological measures (respiration 
and pulse) were compared for differences between 
participants who consumed dietary aspartame intakes of 
equal to or more than 1000 mg per day and who consumed 
less than 1000 mg per day in our study. There were 
statistically significant differences (p=.04) in the mean 
respiration scores when comparing the two groups. This 
finding is not consistent with the results of the study 
by Leon et al. (1989), who concluded that there were no
persistent changes in vital signs (including temperature,
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respiration, blood pressure, and pulse) in participants 
consuming aspartame for 24 weeks. No significant 
differences were found when measuring the effects of 
dietary aspartame consumption on pulse in our study of 
healthy adults. Yet, over 1% of all claims reported to the 
FDA were consequential respiratory symptoms associated 
with aspartame consumption. It is believed that aspartame 
could have an impact on certain neurotransmitters in the 
brain which influence the respiratory center (Aspartame 
Consumer Safety Network, 1996).
Another interesting finding of our study was that 
Self-care Agency had significantly inverse correlation 
with respiration, body weight, the SIR test and the MRT. 
As described by Orem (1995), self-care agency was an 
acquired ability to meet an individual's needs of self 
care. Orem (1995) further pointed out that the capability 
of doing self-care was determined by individuals when 
they were engaged in activities. Due to limited research 
study references in the literature, it is recommended 
that further study may be considered when investigating 
the potential impact of self-care agency on human beings' 
capability of performing activities in their daily lives.
44
Conclusions
To summarize, the findings of our study seem to 
support the hypothesis that aspartame may be related to 
cognitive function as evidenced by aspartame consumption 
equal to or greater than 1000 mg per day based upon the 
MRT. However, these findings are preliminary, and much 
work needs to be done to further substantiate the results 
of our study. Given all of the above and our own 
findings, however, we are skeptical about reports that 
aspartame may be related to neuropsychological and 
neurologic symptoms. Further investigations are necessary 
to clarify this important issue.
It seems that a large amount of aspartame 
consumption might have an impact on human being's 
cognitive function in the long-run. Healthcare 
professionals should assist people to overcome a self- 
care deficit and allow them to further establish 
healthier self-care activities.
Recommendations
Recommendations were made for practice, education, 




Information provided by our study will help to 
increase healthcare professionals' knowledge base about 
the role of the artificial sweetener -- aspartame in 
common food products. Because of increasing use of 
aspartame in food products, it will be beneficial to 
educate individuals regarding the potential risks for 
health problems and potential benefits for eating 
healthier. Although debate on aspartame products has been 
controversial for many years, it may still be possible 
that individuals might not be aware of potential risks 
related to large amount of aspartame consumption.
Our study found that the large amount of aspartame 
consumption (equal to or greater than 1000 mg per day) 
significantly decreased individuals' abilities to perform 
on the MRT. Although the results were not statistically 
significant on the SIR test, it still poses a caution 
about what people eat. These study findings suggest that 
people should be aware of the amount of aspartame 
consumption in daily food intakes, especially less than 
1000 mg per day, since people could easily drink five or 
six cans of carbonated drinks per day without noticing, 
which approximately equal to 1000 mg of aspartame. These 
issues are also education related since knowledge of
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research findings should be translated to clinical 
practice and public healthcare education. Therefore, 
without research findings translated from the "bench to 
bedside," clinical practice cannot be modified to provide 
high-quality care for people.
Research
In conducting our study, several areas of further 
research were suggested. Healthcare professionals should 
be aware of new research findings related to practice and 
education in order to provide more thorough and current 
knowledge to people. As healthcare providers, we also 
need to utilize Orem's Theory to assist people to meet 
their self-care demands.
Recommendations for further research include the 
following:
1. Replication of our study with tighter control of 
variables, such as participants with and without 
long-term dietary aspartame consumption.
2. Replication of our study involving more diverse 
population samples, such as including the elderly 
and the adolescent population.
4. A study comparing control group, placebo group, 
and treatment group on the consumption of 
aspartame food products.
5. Replication of our study following study
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